Industry-Sponsored Satellite Symposia

The Medscape IBS-C Report: Breaking News on Clinical Data and Expert Perspectives

Speaker TBD
6:00 pm – 7:30 pm • Philadelphia Marriott – Salon Ballroom H-J

This innovative symposium format includes 2 faculty 'anchors' and a video-based guest appearance by a patient. The content agenda for the Newscast-Style symposium will include 'Breaking News on IBS-C', 'The Patient Viewpoint on IBS-C', 'Current Concepts in IBS-C Pathophysiology and Targets for Therapy', 'Perspectives From the Street' (a roving reporter in the audience), 'Walking Through Cases' and ending with 15 minutes of Q and A.

Supported by an independent educational grant from Ardelyx.

Exclusive from Philadelphia - Recent Updates on Ulcerative Colitis Treatment: Exploring IL-23 Inhibitors

Bruce E. Sands, MD, MS, FACG; Adam C. Ehrlich, MD, MPH, FACG
5:30 pm – 7:30 pm • Philadelphia Marriott – Salon Ballroom H-J

Join us for an engaging, case-based presentation by Dr. Bruce Sands and Dr. Adam Ehrlich where they will delve into the mechanisms of action, efficacy, safety, and long-term data for IL-23 inhibitors in the treatment of ulcerative colitis.

This event is sponsored by Eli Lilly and Company.

VELSIPITY® (etrasimod): Come learn about an Rx treatment option from Pfizer

Asher Kornbluth, MD
5:30 pm – 7:30 pm • Philadelphia Marriott – Salon Ballroom C-E

Don't miss an exciting presentation from an expert about a prescription treatment option from Pfizer. Join us for a deep dive into efficacy and safety data, identifying appropriate patients, how to get started, and other clinical treatment considerations.

This event is sponsored by Pfizer.

Advances in the Treatment and Management of MASH: More Options, More Decisions

Mazen Noureddin, MD, MHSc, Naga Chalasani, MD, FACG, Mary E. Rinella, MD, FACG
7:30 pm – 9:30 pm • Philadelphia Marriott – Salon Ballroom ABF

This symposium will help you fine-tune your practice by providing practical, interactive discussions of early identification and risk stratification, advances in treatment, monitoring for disease progression, and long-term medical management.

This activity is supported by an independent educational grant from Madrigal Pharmaceuticals.

Register Here

TACKLING INEQUITIES IN IBD Inclusive Solutions for Elevated Patient Care

Sandra Quezada, MD, MS
7:30 pm – 9:30 pm • Philadelphia Marriott – Salon Ballroom GKL

Join us for a dynamic continuing education symposium designed for health care professionals treating patients with IBD. Discover vital insights into the growing impact of health care disparities on patient outcomes and stay ahead with the latest advancements in non-biologic small-molecule drugs,poised to revolutionize the diagnosis and management of Crohn’s disease and ulcerative colitis. Engage with expert speakers, network with peers, and learn collaborative strategies to enhance multidisciplinary teamwork and improve long-term care for patients with IBD.

This activity is supported by educational grants from Takeda and Eli Lilly and Company.

Register Here

How Low Can You Go? Targeting of Deep Remission in the Management of Crohn’s Disease

Bruce E. Sands, MD, MS, FACG (Moderator) ; Marita Kametas, MSN, APN, FNP-BC, CMSRN, COCN; Millie D. Long, MD, MPH, FACG
5:30 am – 7:30 am • Pennsylvania Convention Center – Room 113AB

In this CME Outfitters live symposium, expert faculty will guide learners on how to integrate knowledge of the heterogeneity of CD in severity and manifestation into patient assessment and treatment. Learners will be instructed on utilizing alternative diagnostic and evaluation tools beyond colonoscopy for evaluating symptoms in patients with CD. Faculty will model incorporation of histopathologic treatment targets as an objective measure of inflammation in CD to inform clinical decision-making.

This activity is supported by an educational grant from Lilly.

Register Here for the live in-person event.

Register Here for the virtual stream.

How Does Inflammation Drive Assessment in Crohn’s Disease? The Evolution Continues

Miguel D. Regueiro, MD, FACG; Vipul Jairath, MBChB, DPhil, FRCP, FRCPC
7:30 pm – 9:30 pm • Philadelphia Marriott – Salon Ballroom H-J

Join us for an insightful presentation by Dr. Miguel Regueiro and Dr Vipul Jairath as they explore the inflammatory mechanisms underlying Crohn’s disease and the evolution of its assessment.

This event is sponsored by Eli Lilly and Company.

Managing Gastroesophageal Reflux Disease: Who is in the Waiting Room?

Philip O. Katz, MD, MACG; C. Prakash Gyawali, MD, MRCP, FACG; Rena H. Yadlapati, MD, MSHS, FACG
7:30 pm – 9:30 pm • Philadelphia Marriott – Salon Ballroom C-E

Gastroesophageal reflux disease (GERD) is one of the most common reasons for visits to gastrointestinal (GI) specialists in the United States. Up to half of patients with reflux symptoms do not get adequate relief from empiric therapy with proton pump inhibitors and require more advanced management. In this live, interactive symposium, expert faculty will discuss the latest clinical evidence regarding the diagnosis and management of GERD, erosive esophagitis (EE), and nonerosive reflux disease (NERD), including the evidence for newly approved acid suppressive medications. Faculty will present real-world patient cases to help learners contextualize important clinical information on GERD evaluation and management that they can apply in their own practices.

Supported by an independent educational grant from Phathom Pharmaceuticals.

To Learn More

Next-Level Eosinophilic Esophagitis Care – Embracing Novel Therapies and Strategic Management Solutions

Evan S. Dellon, MD, MPH, FACG; Mirna Chehade, MD, MPH; Glenn Furuta, MD; Kristle L. Lynch, MD
5:30 am – 7:30 am • Philadelphia Marriott – Salon Ballroom LK

Eosinophilic esophagitis (EoE) is a prevalent condition associated with a significant disease burden, largely due to prolonged delays in accurate diagnosis and undertreatment. When left unmanaged, EoE can severely affect a patient’s ability to eat, leading to food impaction, nutritional deficits, and increased healthcare costs. This educational program aims to equip clinicians with the knowledge and skills necessary to optimize diagnosis and management of EoE. Expert faculty will review the latest guideline recommendations and clinical data, highlighting the importance of individualized, evidence-based therapy and interprofessional collaboration for improved patient outcomes. This symposium features Curbside Consults, an interactive and dynamic case-based discussion of best practices for diagnosis and management of EoE in pediatric and adult patients.

This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc. and Sanofi.

Register Here

What’s IL-23 Got to Do With It? Targeted Therapies in the Management of IBD

Marla Dubinsky, MD (Moderator), David P. Hudesman, MD, FACG, Corey A. Siegel, MD, MS
7:00 pm – 9:00 pm • Philadelphia Marriott – Salon Ballroom H-J

In this CME Outfitters hybrid educational symposium, expert faculty will review the functions of Fc gamma receptors, CD64 and its connection with interleukin (IL)-23, the molecular attributes of anti–IL–23 therapies, in vivo data on expression of CD64 monocytes, and the most recent clinical trial data differentiating the anti–IL-23 agents. To demonstrate these concepts, animated 3-D models will be included in the educational program and available to attendees.

This activity is supported by an educational grant from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.- both are Johnson & Johnson companies.

Register Here for the live in-person event.

Register Here for the virtual stream.

Health Maintenance in Inflammatory Bowel Disease

Bruce E. Sands, MD, MS, FACG; Aline Charabaty, MD, FACG
7:00 pm – 9:00 pm • Philadelphia Marriott – Salon Ballroom C-E

This symposium will provide an overview of health maintenance in IBD, review primary and secondary preventative care, and present special populations for consideration for health maintenance.

This program is sponsored by Pfizer.